Cost-Effectiveness Analysis of Real-Time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in People With Type 2 Diabetes Treated With Non-Intensive Insulin Therapy in South Korea [0.03%]
韩国非强化胰岛素治疗的2型糖尿病患者实时连续血糖监测与自我血糖监测的成本效益分析
Ji Yoon Kim,Sabrina Ilham,Hamza Alshannaq et al.
Ji Yoon Kim et al.
Objectives: There is limited evidence regarding the cost-effectiveness of real-time continuous glucose monitoring (rt-CGM) in the management of type 2 diabetes in patients receiving basal insulin regimens in South Korea. ...
iCoDE-2 September 18, 2025 Steering Committee Final Meeting Summary Report [0.03%]
iCoDE-2 第二届指导委员会会议总结报告（2025年9月18日）
Agatha F Scheideman,Mandy M Shao,Simona Carini et al.
Agatha F Scheideman et al.
Glycated Albumin Percentage is Correlated With HbA1c: Theoretic Marker in Patients With Altered Erythrocyte Turnover [0.03%]
糖化白蛋白百分比与HbA1c相关：红细胞周转异常患者的理论标志物
Mats Gåfvels,Per Swärd,Ning Xu et al.
Mats Gåfvels et al.
Introduction: The gold standard for monitoring long-term glucose levels in patients with diabetes mellitus is glycated hemoglobin (HbA1c). In conditions where the erythrocyte half-life is decreased, for example, in long-t...
Continuous Glucose Monitoring Metrics in Asians Without Diabetes: Differentiating Prediabetes From Normoglycemia [0.03%]
持续葡萄糖监测指标在无糖尿病的亚洲人中：区分糖尿病前期和血糖正常者
Suresh Rama Chandran,Gerald Gui Ren Sng,Celine Yu Hui Wong et al.
Suresh Rama Chandran et al.
Background: Early detection of dysglycemia is important to delay the progression to diabetes. Continuous glucose monitoring (CGM) may offer advantages over current diagnostic methods for prediabetes. However, reference in...
Continuous Glucose Monitoring in Older People With Diabetes Mellitus and Cognitive Impairment: A Brief Review [0.03%]
糖尿病伴认知障碍老年人连续葡萄糖监测的简要综述
Busra Donat Ergin,Kieran Gadsby-Davis,Katharina Mattishent et al.
Busra Donat Ergin et al.
Background: Diabetes mellitus and dementia are common chronic diseases affecting older people in the community and in hospitals. Even though both diseases have been independently well-characterized, comorbid diabetes and ...
Managing Hybrid Closed-Loop Insulin Delivery in Complex Clinical Scenarios: Focus on Perioperative, Dialysis, and Glucocorticoid Use [0.03%]
复杂临床情况下胰岛素混合闭环管理：围手术期、透析和使用糖皮质激素的处理要点
Parizad Avari,Catherine Robinson,Lalantha Leelarathna et al.
Parizad Avari et al.
Hybrid closed-loop (HCL) systems have transformed outpatient diabetes management, yet their application in complex inpatient and hospital-based scenarios remains underexplored. This article examines the utilization of HCL systems in three c...
Continuous Glucose Monitoring to Guide Lifestyle Choices With a Focus on Nutrition in the Management of Type 2 Diabetes: A Systematic Review and Meta-Analysis [0.03%]
以营养为重点指导生活方式选择的连续血糖监测在2型糖尿病管理中的作用：系统评价和荟萃分析
Raveendhara R Bannuru,Natalie J Bellini,Richard M Bergenstal et al.
Raveendhara R Bannuru et al.
Objectives: The objective of this systematic review and meta-analysis was to synthesize evidence from randomized controlled trials (RCTs) evaluating the use of continuous glucose monitoring (CGM) to guide lifestyle choice...
The Impact of Interfering Substances on Continuous Glucose Monitors Part 3: A Review of Non-labeled Substances Influencing Continuous Glucose Monitor Readings [0.03%]
干扰物质对连续葡萄糖监测的影响（三）：影响连续葡萄糖监测读数的非标记物质综述
Steven John Setford
Steven John Setford
Presented is a series of narrative reviews that summarize published information regarding the effect or potential effect of interfering substances on the accuracy of continuous glucose monitoring (CGM) devices. While drawing together what i...
Establishment of a Diabetes-Tailored Data Intelligence Platform Enhances Clinical Care, Enables Risk-Based Monitoring, and Facilitates Population-Health-Based Approaches at a Pediatric Diabetes Network [0.03%]
建立糖尿病个性化数据智能平台，改善临床治疗，开展基于风险的监测及面向人口健康的儿科糖尿病网络建设
Brent Lockee,Craig A Vandervelden,Daniel R Tilden et al.
Brent Lockee et al.
Background: Patient-generated health data (PGHD) represents an opportunity to customize care, particularly in type 1 diabetes (T1D) care where continuous glucose monitor (CGM) and insulin pump usage continues to rise. Pre...
The Impact of Interfering Substances on Continuous Glucose Monitors: Part 4: Continuous Glucose Monitoring Interferents: In Vivo Performance, Clinical Implications and Future Standardization [0.03%]
干扰物质对持续葡萄糖监测的影响（四）：持续葡萄糖监测干扰物：体内性能、临床意义及未来标准化
Steven John Setford
Steven John Setford
Presented is a series of narrative reviews that summarize published information regarding the effect or potential effect of interfering substances on the accuracy of continuous glucose monitoring (CGM) devices. Whilst drawing together what ...